Logotype for Brady Corporation

Brady (BRC) Q3 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Brady Corporation

Q3 2025 earnings summary

27 Dec, 2025

Executive summary

  • Achieved record adjusted diluted EPS of $1.22 in Q3 FY2025, up 11.9% year-over-year, with organic sales growth of 1.6% and acquisition-driven growth of 10.5%, bringing total Q3 sales to $382.6 million.

  • Net income for Q3 was $52.3 million, up 2.7% year-over-year; adjusted net income was $58.8 million, up 11.6%.

  • Americas & Asia delivered strong organic sales growth of 5.4% and segment profit up 15% (22.5% margin), while Europe & Australia saw a 5.4% organic sales decline but improved adjusted operating income by 3.8% due to restructuring.

  • Acquisitions of Gravotech, AB & R, and Funai's microfluidic solution business expanded product offerings and contributed to sales growth.

  • Maintained strong liquidity with $152.2 million in cash and $195.2 million available under the credit agreement as of April 30, 2025.

Financial highlights

  • Adjusted diluted EPS rose 11.9% year-over-year to $1.22, a new record; GAAP diluted EPS was $1.09.

  • Total sales grew 11.4% to $382.6 million, with acquisitions contributing 10.5% and foreign currency reducing sales by 0.7%.

  • Gross profit margin was 51%, down from 51.6% last year, mainly due to tariffs and acquisition-related costs.

  • Operating cash flow for Q3 was $59.9 million; nine-month cash from operations was $122.9 million, both down year-over-year due to working capital changes.

  • Returned $44.5 million to shareholders in Q3 via dividends and buybacks; $104.6 million remained under the repurchase program.

Outlook and guidance

  • Tightened adjusted diluted EPS guidance for FY2025 to $4.48–$4.63 per share; GAAP EPS guidance updated to $3.95–$4.10.

  • Expecting low single-digit organic sales growth for the year ending July 31, 2025.

  • Guidance assumes a 20% tax rate, $40 million in depreciation/amortization, and $25 million in capital expenditures.

  • Tariffs expected to impact Q4 by $3–$5 million, net of mitigation.

  • Management expects the annual income tax rate to remain around 21% based on current global business mix and tax laws.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more